Neuraxpharm Group, a European specialty pharmaceutical company focused on the central nervous system, has expanded its operations in Southern Europe with the launch of Neuraxpharm Portugal, it was reported yesterday.
The new office will be part of the company's Southern European Region that includes Italy, Spain and now Portugal.
Javier Mercade, general manager for Italy and Spain, was named as head of the Southern Region earlier this year, which will include Spain, Italy and Portugal. The company has also named Teng Dias as commercial director of the Portugal business.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business